Karin Agerman
Impact in
- Developmental Neuroscience top 1%
- Neurogenesis and neuroplasticity mechanisms
- Biological Psychiatry top 2%
- Tryptophan and brain disorders
Papers in
-
- Neurogenesis and neuroplasticity mechanisms 5
-
- Hearing, Cochlea, Tinnitus, Genetics 4
- Olfactory and Sensory Function Studies 3
- Co-authors
- Patrik Ernfors (10 shared papers)Eero Ċastrén (2 shared papers)Panu Hendolin (2 shared papers)Guilherme Lucas (2 shared papers)Mikko Sairanen (2 shared papers)Barbara Canlon (4 shared papers)Ewen MacDonald (1 shared paper)Eija Koponen (1 shared paper)
- Journals
- Journal of Neurochemistry (1 paper)Journal of Neurocytology (1 paper)Journal of Alzheimer s Disease (1 paper)Biochemical and Biophysical Research Communications (1 paper)Molecular Therapy (1 paper)
- Partner nations
- SwedenItalyUnited States
In The Last Decade
Karin Agerman
18 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 87
- Developmental Neuroscience 318
- Biological Psychiatry 142
- Behavioral Neuroscience 170
- Sensory Systems 226
- Cellular and Molecular Neuroscience 636
Countries citing papers authored by Karin Agerman
This map shows the geographic impact of Karin Agerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Agerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Agerman more than expected).
Fields of papers citing papers by Karin Agerman
This network shows the impact of papers produced by Karin Agerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Agerman. The network helps show where Karin Agerman may publish in the future.
Co-authors
The 25 scholars most cited alongside Karin Agerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 677 | |
| 2 | 2000 | 150 | |
| 3 | 2003 | 94 | |
| 4 | 2013 | 46 | |
| 5 | 2006 | 41 | |
| 6 | 2014 | 36 | |
| 7 | 2012 | 24 | |
| 8 | 2004 | 23 | |
| 9 | 2000 | 23 | |
| 10 | Neurotrophins, NMDA receptors, and nitric oxide in development and protection of the auditory system. | 1999 | 20 |
| 11 | 2010 | 20 | |
| 12 | 2020 | 20 | |
| 13 | 2003 | 19 | |
| 14 | 2003 | 17 | |
| 15 | 2005 | 13 | |
| 16 | Pharmacological strategies for preventing cochlear damage induced by noise trauma. | 1998 | 9 |
| 17 | 2009 | 6 | |
| 18 | 2025 | 2 |
About Karin Agerman
Karin Agerman is a scholar working on Developmental Neuroscience, Sensory Systems, Cellular and Molecular Neuroscience, Physiology and Oncology, having authored 18 papers that have together received 1.2k indexed citations. Recurring topics across this work include Nerve injury and regeneration (7 papers), Neurogenesis and neuroplasticity mechanisms (5 papers), Hearing, Cochlea, Tinnitus, Genetics (4 papers), Alzheimer's disease research and treatments (4 papers), Olfactory and Sensory Function Studies (3 papers), RNA Interference and Gene Delivery (3 papers), Neuropeptides and Animal Physiology (3 papers) and Biochemical Analysis and Sensing Techniques (2 papers). The work is most often cited by research in Developmental Neuroscience (318 citations), Biological Psychiatry (142 citations), Behavioral Neuroscience (170 citations), Sensory Systems (226 citations) and Cellular and Molecular Neuroscience (636 citations). Karin Agerman has collaborated with scholars based in Sweden, Italy and United States. Frequent co-authors include Patrik Ernfors, Eero Ċastrén, Panu Hendolin, Guilherme Lucas, Mikko Sairanen, Barbara Canlon, Ewen MacDonald, Eija Koponen, Annakaisa Haapasalo and Hiroyuki Nawa. Their work appears in journals such as Journal of Neurochemistry, Journal of Neurocytology, Journal of Alzheimer s Disease, Biochemical and Biophysical Research Communications and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.